
































Although age is by far the biggest risk factor for a wide 
range of clinical conditions that are prevalent today, 
old-age survival has increased substantially during the 
past half century. Baby boom generations are growing 
older, the chance of surviving to old age is increasing, 
and the elderly are living longer due to remarkable, 
though largely unexplained, reductions in mortality at 
older ages [1]. Not surprisingly, these puzzling 
biodemographic trajectories are difficult to reconcile 
with present theories about aging. A key assumption 
underlying the theory of evolution holds that fertility 
and survival schedules are fixed − a questionable 
premise for most species in the wild that have evolved 
alternate physiological modes for coping with 
fluctuating environmental conditions including dauer 
states (C. elegans), stationary phase (yeast), diapause 
(certain insects) and hibernation. Furthermore, studies 
in social insects, particularly the honey-bee, have 
revealed that the same genome can be alternatively 
programmed to produce short-lived workers or long-
lived queens.  By and by  we are  coming to realize  that  
 
 
































the evolution of whole organisms’ traits (birth sizes, 
growth rates, age and size at maturity, reproductive 
investment, mortality rates and lifespan) is crucially 
shaped by the interaction of intrinsic and extrinsic 
factors. How the genetic blueprint and environmental 
influences interact with each other is of utmost interest 
especially in aging research. Many lines of evidence, 
including large epidemiological and extensive clinical 
and experimental studies, support the notion that early 
life events strongly influence later susceptibility to 
chronic diseases and mortality rates. An increased 
understanding of the ability of an organism to develop 
in various ways (developmental plasticity), depending 
on a particular environment or settings, provides a 
conceptual basis for these observations and current 
biodemographic trends [2, 3]. 
 
Developmental plasticity requires stable modulation of 
gene expression, and this appears to be mediated, at 
least in part, by epigenetic processes such as DNA 
methylation and histone modification. This concept 


















aging  and  age‐related  diseases  has  gained  interest  given  recent  advances  in  the  understanding  of  how  epigenetic
mechanisms  mediate  the  interactions  between  the  environment  and  the  genetic  blueprint.  While  current  concepts
generally view global deteriorations of epigenetic marks to insidiously impair cellular and molecular functions, an active
role for epigenetic changes in aging has so far received little attention. In this regard, we have recently shown that early‐
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epigenetic marks relate to age-associated declines in 
molecular and cellular functions. Indeed, the current 
literature favors the view that epigenetic mechanisms 
such as DNA methylation deteriorate with age and may 
even accelerate the aging process [4]. A relationship 
between DNA methylation and aging was originally 
proposed in a pioneering study by Berdyshev [5], which 
showed that genomic global DNA methylation 













































support of this finding, a gradual global loss of cytosine 
methylation has been detected in various mouse, rat and 
human tissues [6, 7, 8]. Moreover, different types of 
interspersed repetitive sequences, which make up a 
major fraction of mammalian genomes, appear to be 
targeted at different ages and to varying degrees by age-
associated hypomethylation [9]. This finding is 
compatible with the presence of several mechanisms 
that regulate global hypomethylation and possibly 
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loci have been reported to become hypermethylated 
during aging (the ribosomal gene cluster, the estrogen 
receptor, insulin growth factor, E-cadherin, c-fos etc.; 
reviewed in [10]). In general terms, age-associated 
hypermethylation is thought to preferentially affect loci at 
CpG islands, while loci devoid of CpG islands loose 
methylation with age. In addition, a study in humans has 
revealed that intra-individual changes in DNA 
methylation show some degree of familial clustering, 
indicative of a genetic component [11]. 
 
Taken together, these results seem to imply that early-
life induced programming − in so far that it relies on 
DNA methylation − is at a considerable risk to become 
insidiously disrupted during aging. This erasing might 
curtail any long-lasting programs derived from early-
life conditions. 
 
A recent study in mice sheds new light on this topic. 
Murgatroyd and coworkers [12] showed that early-life 
adversity (daily 3-hour separation of mouse pups from 
their mother during postnatal days 1−10) caused 
persistent hypomethylation at a discrete region of the 
arginine vasopressin (AVP) gene enhancer (Figure 1C) 
in the hypothalamic nucleus paraventricularis (PVN). 
This led to a sustained overexpression of AVP (Figure 
1A), a key activator of the hypothalamo-pituitary 
adrenal (HPA) stress axis. As a result, early-life 
adversity evoked a lifelong elevation in glucocorticoid 
(GC) secretion, heightened endocrine responsiveness to 
stressors, reduced stress coping ability and memory 
deficits. All of these neuroendocrine and behavioral 
alterations are well-known risk factors for aging and 
frequent features of age-associated brain pathologies 
such as major depression and dementia (for review [13, 
14]). 
 
The AVP enhancer is located downstream of the AVP 
gene in the intergenic region (IGR) separating the AVP 
and  oxytocin genes (Figure 1C). Analysis of overall 
CpG methylation across the AVP enhancer revealed that 
the early-life adversity-induced hypomethylation was 
strongest at 6 weeks of age though less prominent in 1-
year aged mice compared to controls (Figure 1B). In 
contrast, control mice alone showed a clear decrease in 
methylation at 1 year of age even though AVP mRNA 
levels remained unaltered (Figure 1A). This finding 
suggests that early-life adversity-induced 
hypomethylation correlated functionally with increased 
AVP transcription and persisted over time, while age-
associated hypomethylation of the AVP enhancer in 
control mice lacked per se a functional correlate. This 
puzzling constellation led the authors to hypothesize 
that single CpG residues at the AVP enhancer behaved 
differentially with respect to early-life versus age-
associated hypomethylation. To elucidate the cause of 
such functional heterogeneity among CpG residues at 
the  AVP enhancer, they went on to correlate CpG 
methylation across the entire enhancer with 
transcriptional activity of the AVP gene. This allowed 
the identification of a number of CpG residues (CpG10 
and CpGs 12-15 dubbed ’methylation landmarks’) that 
strongly correlated with AVP transcription affinity 
DNA-binding sites of the epigenetic reader and writer 
MeCP2 (methyl-CpG-binding protein 2)(Figure 2C). 
MeCP2 serves as a platform upon which synergistic 
crosstalk between histone deacteylation, H3K9 
methylation and DNA methylation is played out to 
confer transcriptional repression and gene silencing (for 
an in depth discussion of MeCP2’s role in AVP 
regulation see [15]). 
 
A comparison of the methylation status of all CpG 
residues in the IGR in 6-week and 1-year aged control 
mice showed that those CpG residues mapping to 
MeCP2 DNA-binding sites (marked in green) did not 
change in the degree of their methylation (Figure 1D). 
In contrast, 30% of the remaining CpG residues 
underwent a significant age-related hypomethylation, 
while only very few CpG residues (3%) showed a 
significant increase. As noted before, this age-
associated hypomethylation did not trigger per se 































MeCP2  (red  lollipops).  Once  established,  these  methylation
landmarks  are  maintained  and  do  not  undergo  further  age‐
associated  changes  in  methylation.  In  contrast,  age‐associated
hypomethylation maps across the entire AVP locus without any
obvious  pattern  or  preference  for  potential  DNA‐binding  sites
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double-faced role of DNA methylation in aging. 
Hereby, specific environmental stimuli (such as early-
life adversity) can induce site-specific changes in DNA 
methylation at critical regulatory sites that underpin 
sustained changes in gene expression subsequently 
influencing the risk of age-associated pathologies. 
These epigenetic changes are actively controlled and 
couple to specific stimuli targeting distinct genes. Due 
to active maintenance mechanisms (albeit this does not 
exclude their extinction by compensatory or 
counteracting processes) these epigenetic marks are 
largely protected from age-associated changes in DNA 
methylation (Figure 2). 
 

















It appears that age-associated genome-wide and site-
specific (de-)methylation can indistinguishably disrupt 
gene expression profiles and lead to the deterioration of 
cellular functions. These processes seem to be 
independent of a specific stimulus during a critical time 
window and take place in multiple, unrelated species. 
Despite some preliminary evidence from humans that 
structural criteria of the DNA (CpG island or the type of 
repetitive element) age-associated changes in 
methylation remain enigmatic. Importantly, however, 
age-associated changes in methylation do not inevitably 
override early life-induced epigenetic programming (in 
fact, age-associated hypomethylation of the AVP 
enhancer had no effect on mRNA expression levels) and 
strengthen the idea that these two processes are 
functionally and mechanistically distinct. Further 
research will be needed to substantiate this concept. 
However, current work on epigenetic programming of 
mice does suggest that differential changes in 
methylation in response to early-life adversity and aging 
apply to other genes in addition to AVP (Y. Wu, 
unpublished data). Certainly, the advancement of 
genome-wide approaches [16] combining high 
resolution analysis and functional studies in the field of 
epigenetics has the potential to accelerate dramatically 
our understanding of the underlying mechanisms in 
aging and age-associated diseases, ultimately opening 
up new possibilities in diagnosis and treatment. 
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